, Tracking Stock Market Picks
Enter Symbol:
Catabasis Pharmaceuticals Inc (CATB) [hlAlert]

down 18.17 %

Catabasis Pharmaceuticals Inc (CATB) rated Outperform with price target $28 by Oppenheimer

Posted on: Monday,  Jul 20, 2015  8:25 AM ET by Oppenheimer

Oppenheimer rated Outperform Catabasis Pharmaceuticals Inc (NASDAQ: CATB) on 07/20/2015, when the stock price was $14.58. Since
then, Catabasis Pharmaceuticals Inc has lost 18.18% as of 08/27/2015's recent price of $11.93.
If you would have followed this Oppenheimer's recommendation on CATB, you would have lost 18.17% of your investment in 38 days.

OppenheimerFunds, Inc. has been helping investors achieve their financial goals since 1960. We are one of the nation's largest and most respected asset management companies. At OppenheimerFunds, we believe that in order for you to reach your financial goals, your investments must perform. That is why investment excellence—over the long term and across the range of our products—is our highest priority. OppenheimerFunds and its controlled affiliates offer a broad range of products and services to individuals, corporations and institutions, including mutual funds, separately managed accounts, investment management for institutions, hedge fund products, qualified retirement plans and subadvisory investment-management services.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/20/2015 8:25 AM Buy
14.58 28.00
as of 8/27/2015
1 Week down  -5.76 %
1 Month   
3 Months   
1 YTD down  -18.17 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy